Compound details
N-[2-(1H-indol-3-yl)ethyl]-4-[(pyrimidin-2-yl)amino]benzamide
| Compound ID | CDAMM00150 |
|---|---|
| Common name | N-[2-(1H-indol-3-yl)ethyl]-4-[(pyrimidin-2-yl)amino]benzamide | IUPAC name | N-[2-(1H-indol-3-yl)ethyl]-4-(pyrimidin-2-ylamino)benzamide |
| Molecular formula | C21H19N5O |
| Retention time | 26.55 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 358.166 | Theoretical mz | 358.166 |
| Error | 0.55 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 4.5187 |
| Inchi key | WIOXQTAGPAMTQH-UHFFFAOYSA-N |
|---|---|
| Smiles | C1=CC=C2C(=C1)C(=CN2)CCNC(=O)C3=CC=C(C=C3)NC4=NC=CC=N4 |
| Superclass | Organoheterocyclic compounds |
| Class | Indoles and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P22303 | ACHE | Acetylcholinesterase | T30082 | SEA |
| O15379 | HDAC3 | Histone deacetylase 3 | T05090 | SEA |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SEA |
| P16083 | NQO2 | Quinone reductase 2 | T75498 | SEA |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SEA |
| Q96RJ0 | TAAR1 | Trace amine-associated receptor 1 (by homology) | T99524 | SEA |
| P28222 | HTR1B | Serotonin 1b (5-HT1b) receptor | T07806 | SEA |
| P28221 | HTR1D | Serotonin 1d (5-HT1d) receptor | T11072 | SEA |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SEA |
| P28566 | HTR1E | Serotonin 1e (5-HT1e) receptor | T84117 | SEA |
| P05164 | MPO | Myeloperoxidase | T23471 | SEA |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SEA |
| P23141 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | T76369 | SEA |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SEA |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SEA |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SEA |
| P22894 | MMP8 | Matrix metalloproteinase 8 | T08856 | SEA |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SEA |
| P03956 | MMP1 | Matrix metalloproteinase 1 | T52450 | SEA |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SEA |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SEA |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SEA |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SEA |
| P25105 | PTAFR | Platelet activating factor receptor | T87023 | SEA |
| P35270 | SPR | Substance-P receptor | T47094 | SEA |
| P07711 | CTSL | Cathepsin L | T98691 | SEA |
| P32245 | MC4R | Melanocortin receptor 4 | T72458 | SEA |
| Q92847 | GHSR | Ghrelin receptor | T59604 | SEA |
| Q01726 | MC1R | Melanocortin receptor 1 | T35842 | SEA |
| P41968 | MC3R | Melanocortin receptor 3 | T76846 | SEA |
| P43116 | PTGER2 | Prostanoid EP2 receptor | T38529 | SEA |
| P11137 | MAP2 | Microtubule-associated protein 2 | T23276 | SEA |
| O75116 | ROCK2 | Rho-associated protein kinase 2 | T06093 | SEA |
| P31749 | AKT1 | Serine/threonine-protein kinase AKT | T67619 | SEA |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SEA |
| P29466 | CASP1 | Caspase-1 | T98269 | SEA |
| Q9Y463 | DYRK1B | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | T82720 | SEA |
| Q6P179 | ERAP2 | Endoplasmic reticulum aminopeptidase 2 | T65818 | SEA |
| P06870 | KLK1 | Kallikrein 1 | T40000 | SEA |
| P48039 | MTNR1A | Melatonin receptor 1A | T97613 | SEA |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SEA |
| P25090 | FPR2 | Lipoxin A4 receptor (by homology) | T97917 | SEA |
| O00311 | CDC7 | CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) | T81358 | SEA |
| P42892 | ECE1 | Endothelin-converting enzyme 1 | T50970 | SEA |
| Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | T98225 | SEA |
| P49840 | GSK3A | Glycogen synthase kinase-3 alpha | T76910 | SEA |
| P49760 | CLK2 | Dual specificity protein kinase CLK2 | T73725 | SEA |
| P35346 | SSTR5 | Somatostatin receptor 5 | T64830 | SEA |
| P30874 | SSTR2 | Somatostatin receptor 2 | T53024 | SEA |
| P31391 | SSTR4 | Somatostatin receptor 4 | T62974 | SEA |
| P30872 | SSTR1 | Somatostatin receptor 1 | T16633 | SEA |
| P32745 | SSTR3 | Somatostatin receptor 3 | T13644 | SEA |
| P32239 | CCKBR | Cholecystokinin B receptor (by homology) | T05849 | SEA |
| P50281 | MMP14 | Matrix metalloproteinase 14 | T65019 | SEA |
| Q9Y243 | AKT3 | Serine/threonine-protein kinase AKT | T71266 | SEA |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SEA |
| Q9UQM7 | CAMK2A | CaM kinase II alpha | T18299 | SEA |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SEA |
| O60760 | HPGDS | Hematopoietic prostaglandin D synthase | T19433 | SEA |
| P43490 | NAMPT | Nicotinamide phosphoribosyltransferase | T54582 | SEA |
| P16234 | PDGFRA | Platelet-derived growth factor receptor | T53524 | SEA |
| P21452 | TACR2 | Neurokinin 2 receptor | T52790 | SEA |
| O15111 | CHUK | Inhibitor of NF-kappa-B kinase (IKK) | T78429 | SEA |
| P22460 | KCNA5 | Voltage-gated potassium channel subunit Kv1.5 | T17569 | SEA |
| P13569 | CFTR | Cystic fibrosis transmembrane conductance regulator | T55654 | SEA |
| P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha 3 | T03279 | SEA |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SEA |
| P19525 | EIF2AK2 | Interferon-induced, double-stranded RNA-activated protein kinase | T04831 | SEA |
| Q9UIQ6 | LNPEP | Cystinyl aminopeptidase | T97537 | SEA |
| O43293 | DAPK3 | Death-associated protein kinase 3 | T81623 | SEA |
| Q13237 | PRKG2 | cGMP-dependent protein kinase 2 | T23606 | SEA |
| P36507 | MAP2K2 | Dual specificity mitogen-activated protein kinase kinase 2 | T89055 | SEA |
| Q13464 | ROCK1 | Rho-associated protein kinase 1 | T51282 | SEA |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SEA |
| Q05513 | PRKCZ | Protein kinase C (PKC) | T59190 | SEA |
| P61073 | CXCR4 | C-X-C chemokine receptor type 4 | T96079 | SEA |
| P40337 | VHL | Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C | T80423 | SEA |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SEA |
| Q5VT25 | CDC42BPA | Serine or threonine-protein kinase MRCK-A | T00075 | SEA |
| O96013 | PAK4 | Serine/threonine-protein kinase PAK 4 | T98293 | SEA |
| P51511 | MMP15 | Matrix metalloproteinase 15 | T81658 | SEA |
| P28336 | NMBR | Neuromedin B receptor | T68887 | SEA |
| P37840 | SNCA | Alpha-synuclein | T03644 | SEA |
| Q96DB2 | HDAC11 | Histone deacetylase 11 | T97903 | SEA |
| P33032 | MC5R | Melanocortin receptor 5 | T95302 | SEA |
| Q04912 | MST1R | Macrophage-stimulating protein receptor | T01973 | SEA |
| P28336 | NMBR | Neuromedin B receptor | T68887 | SEA |
| P30550 | GRPR | Gastrin releasing peptide receptor | T99816 | SEA |
| Q13882 | PTK6 | Tyrosine-protein kinase BRK | T73694 | SEA |
| Q12851 | MAP4K2 | Mitogen-activated protein kinase kinase kinase kinase 2 | T07191 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| Q04756 | HGFAC | Hepatocyte growth factor activator | T38584 | SEA |
| P01275 | GCG | Glucagon | T44919 | SEA |
| O43781 | DYRK3 | Dual-specificity tyrosine-phosphorylation regulated kinase 3 | T97149 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| Q06609 | RAD51 | DNA repair protein RAD51 homolog 1 | T63083 | SEA |
| O35273 | SMAD3 | Mothers against decapentaplegic homolog 3 | T35445 | SEA |
| Q9HAN5 | TRP1 | Cationic trypsinogen | T27602 | SEA |
| P35270 | SPR | Substance-P receptor | T47094 | SEA |
| P24347 | MMP11 | Matrix metalloproteinase-11 | T73180 | SEA |
| P05981 | HPN | Serine protease hepsin | T73471 | SEA |
| Q9ULZ9 | MMP17 | Matrix metalloproteinase-17 | T55616 | SEA |
| Q96BR1 | SGK3 | Serum-and glucocorticoid-inducible kinase SGK | T64102 | SEA |
| P26927 | MST1 | MST-1 protein kinase | T47164 | SEA |
| P40238 | MPL | Thrombopoietin receptor | T16156 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T05090 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O15379 | HDAC3 |
| T05090 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15379 | HDAC3 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T75498 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P16083 | NQO2 |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T99524 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q96RJ0 | TAAR1 |
| T99524 | DI0149 | Focal/segmental autonomic disorder | [ICD-11: 8D8A] | Q96RJ0 | TAAR1 |
| T99524 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q96RJ0 | TAAR1 |
| T07806 | DI0264 | Migraine | [ICD-11: 8A80] | P28222 | HTR1B |
| T07806 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28222 | HTR1B |
| T07806 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P28222 | HTR1B |
| T07806 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28222 | HTR1B |
| T11072 | DI0264 | Migraine | [ICD-11: 8A80] | P28221 | HTR1D |
| T11072 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28221 | HTR1D |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T84117 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28566 | HTR1E |
| T23471 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P05164 | MPO |
| T23471 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P05164 | MPO |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T76369 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P23141 | CES1 |
| T76369 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P23141 | CES1 |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T08856 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P22894 | MMP8 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T52450 | DI0238 | Lung cancer | [ICD-11: 2C25] | P03956 | MMP1 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T87023 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P25105 | PTAFR |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T98691 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P07711 | CTSL |
| T98691 | DI0376 | Severe acute respiratory syndrome | [ICD-11: 1D65] | P07711 | CTSL |
| T72458 | DI0192 | Hypoactive sexual desire dysfunction | [ICD-11: HA00] | P32245 | MC4R |
| T72458 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P32245 | MC4R |
| T72458 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P32245 | MC4R |
| T59604 | DI0087 | Chronic pain | [ICD-11: MG30] | Q92847 | GHSR |
| T59604 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | Q92847 | GHSR |
| T35842 | DI0192 | Hypoactive sexual desire dysfunction | [ICD-11: HA00] | Q01726 | MC1R |
| T35842 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | Q01726 | MC1R |
| T76846 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P41968 | MC3R |
| T76846 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P41968 | MC3R |
| T76846 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P41968 | MC3R |
| T38529 | DI0003 | Abortion | [ICD-11: JA00] | P43116 | PTGER2 |
| T38529 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P43116 | PTGER2 |
| T38529 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P43116 | PTGER2 |
| T38529 | DI0166 | Glaucoma | [ICD-11: 9C61] | P43116 | PTGER2 |
| T38529 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P43116 | PTGER2 |
| T38529 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P43116 | PTGER2 |
| T38529 | DI0413 | Transplant rejection | [ICD-11: NE84] | P43116 | PTGER2 |
| T23276 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P11137 | MAP2 |
| T23276 | DI0252 | Melanoma | [ICD-11: 2C30] | P11137 | MAP2 |
| T23276 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P11137 | MAP2 |
| T23276 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11137 | MAP2 |
| T06093 | DI0168 | Graft-versus-host disease | [ICD-11: 4B24] | O75116 | ROCK2 |
| T67619 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P31749 | AKT1 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T98269 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P29466 | CASP1 |
| T98269 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P29466 | CASP1 |
| T98269 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P29466 | CASP1 |
| T98269 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P29466 | CASP1 |
| T97613 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P48039 | MTNR1A |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T97917 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P25090 | FPR2 |
| T81358 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00311 | CDC7 |
| T81358 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O00311 | CDC7 |
| T76910 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P49840 | GSK3A |
| T64830 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P35346 | SSTR5 |
| T53024 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P30874 | SSTR2 |
| T53024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P30874 | SSTR2 |
| T53024 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30874 | SSTR2 |
| T62974 | DI0087 | Chronic pain | [ICD-11: MG30] | P31391 | SSTR4 |
| T62974 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P31391 | SSTR4 |
| T16633 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P30872 | SSTR1 |
| T16633 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P30872 | SSTR1 |
| T13644 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P32745 | SSTR3 |
| T05849 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P32239 | CCKBR |
| T05849 | DI0327 | Pancreatic internal secretion disorder | [ICD-11: 5A4Y] | P32239 | CCKBR |
| T65019 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P50281 | MMP14 |
| T71266 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9Y243 | AKT3 |
| T18299 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UQM7 | CAMK2A |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T19433 | DI0148 | Flatworm infection | [ICD-11: 1F70-1F86] | O60760 | HPGDS |
| T54582 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P43490 | NAMPT |
| T54582 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P43490 | NAMPT |
| T54582 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P43490 | NAMPT |
| T53524 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P16234 | PDGFRA |
| T53524 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P16234 | PDGFRA |
| T53524 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P16234 | PDGFRA |
| T52790 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P21452 | TACR2 |
| T78429 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | O15111 | CHUK |
| T17569 | DI0030 | Angina pectoris | [ICD-11: BA40] | P22460 | KCNA5 |
| T55654 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P13569 | CFTR |
| T55654 | DI0217 | Intrathoracic organs injury | [ICD-11: NB32] | P13569 | CFTR |
| T55654 | DI0435 | Viral intestinal infection | [ICD-11: 1A2Z] | P13569 | CFTR |
| T03279 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P51812 | RPS6KA3 |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T89055 | DI0252 | Melanoma | [ICD-11: 2C30] | P36507 | MAP2K2 |
| T89055 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P36507 | MAP2K2 |
| T51282 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q13464 | ROCK1 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T59190 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q05513 | PRKCZ |
| T96079 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P61073 | CXCR4 |
| T96079 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P61073 | CXCR4 |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T98293 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O96013 | PAK4 |
| T98293 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O96013 | PAK4 |
| T68887 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P28336 | NMBR |
| T68887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28336 | NMBR |
| T03644 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P37840 | SNCA |
| T03644 | DI0044 | Autonomic nervous system disorder | [ICD-11: 8D87] | P37840 | SNCA |
| T03644 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P37840 | SNCA |
| T95302 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P33032 | MC5R |
| T95302 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P33032 | MC5R |
| T01973 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q04912 | MST1R |
| T68887 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P28336 | NMBR |
| T68887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28336 | NMBR |
| T99816 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P30550 | GRPR |
| T99816 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P30550 | GRPR |
| T99816 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P30550 | GRPR |
| T73694 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | Q13882 | PTK6 |
| T73694 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q13882 | PTK6 |
| T07191 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q12851 | MAP4K2 |
| T44919 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P01275 | GCG |
| T44919 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P01275 | GCG |
| T44919 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P01275 | GCG |
| T44919 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P01275 | GCG |
| T44919 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P01275 | GCG |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T63083 | DI0048 | B-cell lymphoma | [ICD-11: 2A86] | Q06609 | RAD51 |
| T63083 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q06609 | RAD51 |
| T35445 | DI0226 | Kidney fibrosis | [ICD-11: GC01] | O35273 | SMAD3 |
| T27602 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q9HAN5 | TRP1 |
| T27602 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9HAN5 | TRP1 |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T47164 | Di0221 | Ischemic heart disease | [ICD-11: BA40-BA6Z] | P26927 | MST1 |
| T16156 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P40238 | MPL |